NASDAQ:MYGN Investor Notice: Lawsuit Alleges Misleading Statements by Myriad Genetics, Inc.
An investor, who purchased shares of Myriad Genetics, Inc. (NASDAQ: MYGN), filed a lawsuit over alleged violations of Federal Securities Laws by Myriad Genetics, Inc.
View full press release